1700001N15Rik Activators
1700001N15Rik Activators encompass a diverse array of chemical compounds that indirectly stimulate the functional activity of 1700001N15Rik through various specific signaling pathways. For instance, Forskolin and Sildenafil, by increasing intracellular levels of cAMP and cGMP respectively, initiate a cascade of phosphorylation events through PKA and PKG. 1700001N15Rik Activators are a specialized set of chemical compounds that serve to indirectly augment the functional activity of the 1700001N15Rik protein through unique and specific signaling pathways or biological processes. Forskolin, by raising cAMP levels, activates PKA which in turn could phosphorylate proteins that interact with 1700001N15Rik, leading to its enhanced activity. Similar indirect activation could be postulated for Ionomycin, which increases calcium ion concentration in the cytoplasm and potentially promotes the activity of calcium-dependent kinases that might phosphorylate and activate 1700001N15Rik.
Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8), both PKC activators, could phosphorylate substrates that interact with or modulate 1700001N15Rik, enhancing its function. The inhibition of PDE5 by Sildenafil and Zaprinast, which results in elevated cGMP levels, could similarly engage signaling pathways leading to the activation of 1700001N15Rik. Furthermore, the PI3K pathway, often pivotal in cellular signaling, can be modulated by LY294002; this inhibition could create a signaling milieu that favors 1700001N15Rik activation. SB203580 and U0126, which specifically inhibit p38 MAPK and MEK1/2 respectively, may result in the upregulation of signaling pathways that activate 1700001N15Rik as the cell compensates for the inhibited pathways. 2-Aminoethoxydiphenyl borate (2-APB) alters intracellular calcium signaling, potentially affecting 1700001N15Rik if its activity is calcium-dependent. The polyphenol Epigallocatechin gallate (EGCG) inhibits various kinases, possibly alleviating negative regulation on 1700001N15Rik and thus enhancing its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. This elevation in calcium can activate calcium-dependent signaling pathways that may intersect with 1700001N15Rik's activity, enhancing its functional role in cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to the phosphorylation of substrates that might interact with or modify 1700001N15Rik, leading to its enhanced activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that modulates the PI3K/Akt/mTOR pathway. Inhibition of this pathway can lead to altered signaling dynamics that might favor the activation of 1700001N15Rik through compensatory mechanisms within the cell. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38, it can shift the signaling equilibrium within the cell, potentially upregulating or enhancing signaling pathways that activate 1700001N15Rik. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB modulates intracellular calcium release by affecting IP3 receptors. Altered calcium signaling may enhance the activity of 1700001N15Rik if it is regulated by calcium-dependent processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit various kinases. By inhibiting competitive signaling pathways, it may upregulate or enhance the activity of 1700001N15Rik if the protein is negatively regulated by those kinases. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is another PDE5 inhibitor, like Sildenafil, which can increase cGMP levels and potentially enhance signaling pathways that lead to the activation of 1700001N15Rik. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. JNK pathway activation can result in the modulation of transcription factors and proteins that may interact with or activate 1700001N15Rik. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is a synthetic analog of diacylglycerol that activates PKC. Activation of PKC may enhance the phosphorylation status of proteins related to 1700001N15Rik's function or pathway, thus enhancing its activity. | ||||||